25-(OH)VitD3, as a Risk Indicator in Diagnosis of Adenocarcinoma

MLA

Chi-Meng Tzeng, et al. “25-(OH)VitD3, as a Risk Indicator in Diagnosis of Adenocarcinoma.” Current Drug Targets, vol. 14, Sept. 2013, pp. 1367–76. EBSCOhost, https://doi.org/10.2174/13894501113149990204.

APA

Chi-Meng Tzeng, Li-Mou Zheng, Hui-Ming Ye, Xiao-Nan Lv, Yun-Long Wu, Huan-jing Zhang, & Liang-Liang Cai. (2013). 25-(OH)VitD3, as a Risk Indicator in Diagnosis of Adenocarcinoma. Current Drug Targets, 14, 1367–1376. https://doi.org/10.2174/13894501113149990204

Chicago

Chi-Meng Tzeng, Li-Mou Zheng, Hui-Ming Ye, Xiao-Nan Lv, Yun-Long Wu, Huan-jing Zhang, and Liang-Liang Cai. 2013. “25-(OH)VitD3, as a Risk Indicator in Diagnosis of Adenocarcinoma.” Current Drug Targets 14 (September): 1367–76. doi:10.2174/13894501113149990204.